Àlvaro Aytés

2.5k total citations
20 papers, 1.4k citations indexed

About

Àlvaro Aytés is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Àlvaro Aytés has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Àlvaro Aytés's work include Prostate Cancer Treatment and Research (9 papers), DNA Repair Mechanisms (2 papers) and Epigenetics and DNA Methylation (2 papers). Àlvaro Aytés is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), DNA Repair Mechanisms (2 papers) and Epigenetics and DNA Methylation (2 papers). Àlvaro Aytés collaborates with scholars based in Spain, United States and United Kingdom. Àlvaro Aytés's co-authors include Cory Abate‐Shen, Andrea Califano, Michael M. Shen, Antonina Mitrofanova, Céline Lefèbvre, Alberto Villanueva, Mireia Castillo-Martín, Tian Zheng, Mariano J. Alvarez and Carolyn Waugh Kinkade and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Àlvaro Aytés

20 papers receiving 1.4k citations

Peers

Àlvaro Aytés

PRM

ONCOL

IMMUN

Jean‐Claude Cutz Canada

Holger H.H. Erb Germany

Yuqian Yan United States

Santhosh Kumar Karthikeyan United States

Yunqian Pan United States

Hailong Ruan China

Katharine Ellwood‐Yen United States

Huaitian Liu United States

Xiao‐En Xu China

Jérôme Durivault France

Jean‐Claude Cutz Canada

Àlvaro Aytés

666 ×0.7

319 ×0.6

370 ×0.8

PRM

403 ×1.3

ONCOL

104 ×0.9

IMMUN

Citations per year, relative to Àlvaro Aytés Àlvaro Aytés (= 1×) peers Jean‐Claude Cutz

Countries citing papers authored by Àlvaro Aytés

Since Specialization

Citations

This map shows the geographic impact of Àlvaro Aytés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Àlvaro Aytés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Àlvaro Aytés more than expected).

Fields of papers citing papers by Àlvaro Aytés

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Àlvaro Aytés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Àlvaro Aytés. The network helps show where Àlvaro Aytés may publish in the future.

Co-authorship network of co-authors of Àlvaro Aytés

This figure shows the co-authorship network connecting the top 25 collaborators of Àlvaro Aytés. A scholar is included among the top collaborators of Àlvaro Aytés based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Àlvaro Aytés. Àlvaro Aytés is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Huabin, Carmen Serra, Wenjie Zhang, et al.. (2024). Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite. Cell chemical biology. 31(5). 973–988.e4. 1 indexed citations

Poulard, Coralie, Montserrat Abella, Rosa Antón, et al.. (2023). A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance. Science Advances. 9(11). eade2175–eade2175. 12 indexed citations

Paull, Evan, Àlvaro Aytés, Sunny J. Jones, et al.. (2021). A modular master regulator landscape controls cancer transcriptional identity. Cell. 184(2). 334–351.e20. 56 indexed citations

Porras, Vicenç Ruiz de, Albert Font, & Àlvaro Aytés. (2021). Chemotherapy in metastatic castration-resistant prostate cancer: Current scenario and future perspectives. Cancer Letters. 523. 162–169. 43 indexed citations

Liu, Qi, Luís Palomero, Roderic Espín, et al.. (2021). Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types. Science Translational Medicine. 13(580). 36 indexed citations

Benavente, Yolanda, Jordi Ponce, Joan Brunet, et al.. (2020). Sensitivity of cervico‐vaginal cytology in endometrial carcinoma: A systematic review and meta‐analysis. Cancer Cytopathology. 128(11). 792–802. 32 indexed citations

Nombela, Paz, Rebeca Lozano, Àlvaro Aytés, et al.. (2019). BRCA2 and Other DDR Genes in Prostate Cancer. Cancers. 11(3). 352–352. 67 indexed citations

Ruggero, Katia, et al.. (2018). Epigenetic Regulation in Prostate Cancer Progression. PubMed. 4(2). 101–115. 44 indexed citations

Aytés, Àlvaro, Arianna Giacobbe, Antonina Mitrofanova, et al.. (2018). NSD2 is a conserved driver of metastatic prostate cancer progression. Nature Communications. 9(1). 5201–5201. 68 indexed citations

10.

Mitrofanova, Antonina, Àlvaro Aytés, Min Zou, et al.. (2015). Predicting Drug Response in Human Prostate Cancer from Preclinical Analysis of In Vivo Mouse Models. Cell Reports. 12(12). 2060–2071. 28 indexed citations

11.

Aytés, Àlvaro, Antonina Mitrofanova, Céline Lefèbvre, et al.. (2014). Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy. Cancer Cell. 25(5). 638–651. 233 indexed citations

12.

Aytés, Àlvaro, Antonina Mitrofanova, Carolyn Waugh Kinkade, et al.. (2013). ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer. Proceedings of the National Academy of Sciences. 110(37). E3506–15. 102 indexed citations

13.

Irshad, Shazia, Mukesh Bansal, Mireia Castillo-Martín, et al.. (2013). A Molecular Signature Predictive of Indolent Prostate Cancer. Science Translational Medicine. 5(202). 202ra122–202ra122. 103 indexed citations

14.

Floc’h, Nicolas, Carolyn Waugh Kinkade, Takashi Kobayashi, et al.. (2012). Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model. Cancer Research. 72(17). 4483–4493. 68 indexed citations

15.

Wang, Jingqiang, Takashi Kobayashi, Nicolas Floc’h, et al.. (2012). B-Raf Activation Cooperates with PTEN Loss to Drive c-Myc Expression in Advanced Prostate Cancer. Cancer Research. 72(18). 4765–4776. 78 indexed citations

16.

Aytés, Àlvaro, David G. Mollevı́, María Martínez‐Iniesta, et al.. (2011). Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype. Molecular Carcinogenesis. 51(9). 746–753. 48 indexed citations

17.

Melo, Sónia A., Alberto Villanueva, Cátia Moutinho, et al.. (2011). Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proceedings of the National Academy of Sciences. 108(11). 4394–4399. 194 indexed citations

18.

Mollevı́, David G., Àlvaro Aytés, Mireia Berdiel‐Acer, et al.. (2009). PRL-3 overexpression in epithelial cells is induced by surrounding stromal fibroblasts. Molecular Cancer. 8(1). 46–46. 7 indexed citations

19.

Mollevı́, David G., Àlvaro Aytés, Laura Padullés, et al.. (2008). PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness. British Journal of Cancer. 99(10). 1718–1725. 34 indexed citations

20.

Fernández‐Majada, Vanesa, Concepción M. Aguilera, Alberto Villanueva, et al.. (2006). Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer. Proceedings of the National Academy of Sciences. 104(1). 276–281. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact